Xenogesis Limited
Dormant Company · Nottingham
ActiveUnited KingdomIncorporated 2011Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
Accounts to 2016-03-31
IXBRL · 91 source facts · 22 selected values
Not assessedlegacy record
Accounts to 2016-03-31
IXBRL · 91 source facts · 22 selected values
Not assessed
legacy record
- Reporting period
- 2015-04-01 to 2016-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 41
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-full-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0035_07541784_20160331
- Source archive
- Accounts_Monthly_Data-October2016.zip
Accounts to 2015-03-31
IXBRL · 85 source facts · 20 selected values
Not assessedlegacy record
Accounts to 2015-03-31
IXBRL · 85 source facts · 20 selected values
Not assessed
legacy record
- Reporting period
- 2014-04-01 to 2015-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 36
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-full-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0023_07541784_20150331
- Source archive
- Accounts_Monthly_Data-October2015.zip
Accounts to 2014-03-31
IXBRL · 84 source facts · 20 selected values
Not assessedlegacy record
Accounts to 2014-03-31
IXBRL · 84 source facts · 20 selected values
Not assessed
legacy record
- Reporting period
- 2013-04-01 to 2014-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 36
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-full-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_0013_07541784_20140331
- Source archive
- Accounts_Monthly_Data-December2014.zip
Accounts to 2013-03-31
IXBRL · 89 source facts · 20 selected values
Not assessedlegacy record
Accounts to 2013-03-31
IXBRL · 89 source facts · 20 selected values
Not assessed
legacy record
- Reporting period
- 2012-04-01 to 2013-03-31
- Extraction status
- Legacy / not assessed
- Numeric facts
- 40
- Documents processed
- Not recorded
- XBRL standards validation
- Not assessed
- Filing-profile validation
- Not assessed
- Parser
- Legacy parser
- Taxonomy
- uk-gaap-full-2009-09-01.xsd
- Currency
- GBP
- Source identifier
- Prod224_9993_07541784_20130331
- Source archive
- Accounts_Monthly_Data-August2013.zip
Registered details
07541784- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2011-02-24
- Jurisdiction
- —
- Registered office
- DISCOVERY BUILDING, BIOCITY, NOTTINGHAM, NG1 1GR, UNITED KINGDOM
Classification
1 SIC codes99999
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
0 SH01-derived roundsNo reconstructed allotment rounds.
Research and innovation
4 matched grantsUnderstanding the Emerging Role of the Spleen in the Disposition of Novel Precision MedicinesBBSRC · Studentship · 2019-09-30 – 2024-02-26 · with 1 other participant£0whole project
Understanding the Emerging Role of the Spleen in the Disposition of Novel Precision Medicines
BBSRC · Studentship · 2019-09-30 – 2024-02-26 · with 1 other participant
£0
whole project
University Of NottinghamleadXenoGesis Ltd
Development and validation of a dynamic drug screening platform for ADME testing .Innovate UK · Feasibility Studies · 2014-10-01 – 2016-06-30 · with 2 other participants£54,021awarded
Development and validation of a dynamic drug screening platform for ADME testing .
Innovate UK · Feasibility Studies · 2014-10-01 – 2016-06-30 · with 2 other participants
£54,021
awarded
3D cell culture model for studying Non-Alcoholic Fatty Liver Disease (NAFLD).Innovate UK · Feasibility Studies · 2014-09-01 – 2015-11-30 · with 1 other participant£40,483awarded
3D cell culture model for studying Non-Alcoholic Fatty Liver Disease (NAFLD).
Innovate UK · Feasibility Studies · 2014-09-01 – 2015-11-30 · with 1 other participant
£40,483
awarded
XenoGesis£40,483
Evaluation of membrane-retentive pro-drugs to increase duration of effect to enable once-a-day dosing of inhaled muscarinic M3 receptor antagonistsLeadInnovate UK · Feasibility Studies · 2013-04-01 – 2014-06-30 · with 1 other participant£67,744awarded
Evaluation of membrane-retentive pro-drugs to increase duration of effect to enable once-a-day dosing of inhaled muscarinic M3 receptor antagonistsLead
Innovate UK · Feasibility Studies · 2013-04-01 – 2014-06-30 · with 1 other participant
£67,744
awarded
University of Nottingham£80,768
XenoGesislead£67,744